NfL as a biomarker for neurodegeneration and survival in Parkinson

Por um escritor misterioso

Descrição

NfL as a biomarker for neurodegeneration and survival in Parkinson
NfL as a biomarker for neurodegeneration and survival in Parkinson
NfL as a biomarker for neurodegeneration and survival in Parkinson
Serum neurofilament light levels are predictive of all-cause
NfL as a biomarker for neurodegeneration and survival in Parkinson
Blood NfL Neurology
NfL as a biomarker for neurodegeneration and survival in Parkinson
JPM, Free Full-Text
NfL as a biomarker for neurodegeneration and survival in Parkinson
Advances in the Research of Risk Factors and Prodromal Biomarkers
NfL as a biomarker for neurodegeneration and survival in Parkinson
Neurofilament light chain as a mediator between LRRK2 mutation and
NfL as a biomarker for neurodegeneration and survival in Parkinson
NfL as a biomarker for neurodegeneration and survival in Parkinson
NfL as a biomarker for neurodegeneration and survival in Parkinson
Major advances in Parkinson's disease over the past two decades
NfL as a biomarker for neurodegeneration and survival in Parkinson
NfL as a biomarker for neurodegeneration and survival in Parkinson
NfL as a biomarker for neurodegeneration and survival in Parkinson
Neurofilament light chain is increased in the parahippocampal
NfL as a biomarker for neurodegeneration and survival in Parkinson
Frontiers Neurofilament light as a biomarker for motor decline
de por adulto (o preço varia de acordo com o tamanho do grupo)